Matt Davidson, 10% Owner at Verrica Pharmaceuticals Inc. (VRCA), sold 3,900 shares at $9.60 ($36K) on 2019-05-03, disclosed to the SEC on 2019-05-07.
Scheduled sale ($36k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.60 | 1,200 | $12K | 31.8% |
| 2 | $9.37 | 1,200 | $11K | 31.1% |
| 3 | $8.94 | 1,500 | $13K | 37.1% |
| Total | $9.28 avg | 3,900 | $36K | 100% |
| Filing → |
| VRCA | SELL | 2019-08-09 | $66K | — | Filing → |
| VRCA | SELL | 2019-08-06 | $66K | — | Filing → |
| VRCA | SELL | 2019-08-01 | $181K | — | Filing → |